BioSpace News Archive

Mavorixafor is a potential first-in-class, once-daily, oral, small molecule antagonist of chemokine receptor CXCR4, and is currently being investigated in a pivotal Phase 3 global clinical trial, 4WHIM, for the treatment of WHIM syndrome.

Guidance for professionals and individuals who are struggling with depression and anxiety.

Chaired by award-winning dermatologist Seth B. Forman, MD, of ForCare Medical Group in Tampa, FL, the study will assess weekly bermekimab therapy to reduce inflammatory skin lesions, itch, and pain in patients suffering from eczema.

53% of Patients Achieve Undetectable or BLOQ HDV RNA at Week 24

Bend Financial (Bend), the leader in health savings account and financial wellness technologies, today announced that it has been selected by Paragon Benefits to provide the health savings account (HSA) technology solution for the 250 banks, 40 self-funded accounts and hundreds of cafeteria plans that it manages healthcare expenses for.

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Dova Pharmaceuticals, Inc. (Dova) (NASDAQ: DOVA) announced today the completion of the acquisition of Dova by Sobi.

Baystate Health, the premier integrated health system serving more than 800,000 patients in western New England, announced a strategic partnership with Life Imag

NorthBay Healthcare, an independent nonprofit health system in Northern California, has selected the GenomeBrain Platform for a pilot program planned to improve the routine use of genetic testing in patient care.

NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, announced today that Dietrich Stephan, Chief Executive Officer of NeuBase, will present a corporate overview and business update at the Stifel 2019 Healthcare Conference, which is being held from November 19th to 20th in New York City.

Amp Human, creators of PR Lotion, announced today that Dr. Brad Wilkins has joined the company as Vice President of Science and Innovation.